Participate in a Clinical Trial

Without the participation of people with MS, it would be impossible to develop new and better therapies and other interventions.

Clinical Trials in MS

The latest clinical research in MS, including trials funded by the Society and trials in progressive MS.

NARCOMS Patient Registry

Register as a willing MS research participant to facilitate multicenter studies. Initiated by the Consortium of MS Centers.

Visit NARCOMS

Posting a Trial

If you would like us to post a study on these pages, please email studies@nmss.org to find out what information you need to submit for review.

Clinical Trials In Your Area

Interested in clinical trials? Simply search by state, type of MS or keyword and see what’s going on in your area.

Clinical Trial: Plant-Derived Oral Cannabinoid Spray to Treat Muscle Spasticity

SUMMARY: Investigators are recruiting 446 people with MS worldwide who are being treated for spasticity for a study testing whether adding nabiximols (an oral spray), to ongoing antispasticity therapy can reduce MS-related muscle spasms. The study is sponsored by Jazz Pharmace...

Get Details
Clinical Trial: Fenebrutinib

A study to evaluate the effectiveness and safety of fenebrutinib on disability progression and relapse rate. Eligible participants will be randomly assigned to receive either fenebrutinib or teriflunomide. Some may then receive fenebrutinib during an open label extension.

Get Details
Clinical Trial: Comparing Experimental Fenebrutinib to Aubagio® in Relapsing MS

Investigators in the U.S. and abroad are recruiting a total of 1468 people with relapsing forms of MS for two separate studies comparing investigational oral fenebrutinib with Aubagio ® (teriflunomide, Sanofi Genzyme). The studies – also called FENhance – are sponsored by F....

Get Details
Clinical Trial: Comparing Experimental Fenebrutinib to Ocrevus® in Primary Progressive MS

Investigators in the U.S. and abroad are recruiting 946 people with primary progressive MS for a study comparing investigational oral fenebrutinib with Ocrevus ® (ocrelizumab - Genentech, a member of the Roche Group). The study – also called FENtrepid – is sponsored by F. H...

Get Details
Clinical Trial: ofatumumab

A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient- reported outcomes in people with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy. FDA Approved medication (Brand na...

Get Details
Clinical Trial: Behavioral intervention for MS (via Zoom)

Researchers at Kessler Foundation are studying whether a series of online classes based on cognitive behavioral therapy and positive psychology principles may improve self-efficacy, coping, psychological well-being, and quality of life in multiple sclerosis (MS). Participation...

Get Details
Clinical Trial: Impact of Vancomycin on the Gut Microbiome and Immune Function in MS

The goal of this study is to see if changes in the gut microbiome can alter multiple sclerosis outcomes. Participants are newly diagnosed with MS (symptoms onset lest than 6 months) who have never taken disease-modifying treatment. Participants will take vancomycin, an antib...

Get Details
Clinical Trial:IMU-838

Following a 4-week screening period, participants will take either oral IMU-838 or placebo for a period of 72 weeks during the main period of the study. Participants may need to stop taking certain MS medications during the trial. An MRI scan will be needed during screening p...

Get Details
Clinical Trial: Improving New Learning and Memory in MS

The Kessler Foundation is currently recruiting for a study on memory. Participants will be compensated.. The study involves paper-and-pencil testing and is intended to assess the efficacy of learning and memory techniques within the Multiple Sclerosis population. Additionally,...

Get Details
Clinical Trial: Ocrelizumab for Preventing MS in Individuals With Radiologically Isolated Disease

“Radiologically isolated syndrome” (RIS) is diagnosed when it is discovered that someone has brain MRI abnormalities similar in appearance and location to abnormalities seen in people with MS. People with RIS are typically otherwise healthy and without any symptoms common for ...

Get Details

|< < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 > >|

Discover More

Here are a few related topics that may interest you

The National MS Society is Here to Help

Need More Information?

We Are Here

Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online.

Contact an MS Navigator

Newly Diagnosed

If you or somone close to you has recently been diagnosed, access our MS information and resources.

Start Here

Featured Links: >

Participate in a Clinical Trial

Clinical Trials in MS

NARCOMS Patient Registry

Posting a Trial

Share

Clinical Trials In Your Area

Clinical Trial: Plant-Derived Oral Cannabinoid Spray to Treat Muscle Spasticity

Clinical Trial: Fenebrutinib

Clinical Trial: Comparing Experimental Fenebrutinib to Aubagio® in Relapsing MS

Clinical Trial: Comparing Experimental Fenebrutinib to Ocrevus® in Primary Progressive MS

Clinical Trial: ofatumumab

Clinical Trial: Behavioral intervention for MS (via Zoom)

Clinical Trial: Impact of Vancomycin on the Gut Microbiome and Immune Function in MS

Clinical Trial:IMU-838

Clinical Trial: Improving New Learning and Memory in MS

Clinical Trial: Ocrelizumab for Preventing MS in Individuals With Radiologically Isolated Disease

Share

Discover More

The National MS Society is Here to Help

We Are Here